PNA Bridge Solves the Problem of Cell-Penetrating Peptides Interfering with Cargo
A peptide nucleic acid (PNA) bridge allows cell-penetrating peptides to deliver functional cargo without interfering with its activity inside cells.
Quick Facts
What This Study Found
The core problem: cell-penetrating peptides (CPPs) have positive charges that can interfere with the function of attached cargo peptides inside cells. Direct conjugation often does not work reliably.
The solution: an 8-unit PNA sequence conjugated to octa-arginine CPP (PNA1-CPP) paired with a complementary PNA attached to an autophagy-inducing peptide (PNA2-AIP). The two PNA strands hybridized, forming a stable 1:1 complex that kept the functional peptide connected to the CPP during delivery.
Once inside cells, at least some of the PNA1-CPP/PNA2-AIP complexes dissociated, releasing the functional AIP from the positively charged CPP. The released PNA2-AIP induced significantly more autophagy than AIP directly conjugated to CPP (CPP-AIP). The PNA hybrid system also caused minimal cell death.
Key Numbers
8-mer PNA bridge; 1:1 hybrid; improved autophagy vs direct conjugation; minimal cytotoxicity
How They Did This
In vitro cell culture study. Researchers synthesized PNA-peptide conjugates using solid-phase peptide synthesis, confirmed 1:1 hybrid formation, measured cellular uptake, tracked intracellular dissociation, quantified autophagy induction (compared to direct CPP-AIP conjugate), and assessed cell viability.
Why This Research Matters
Getting therapeutic peptides inside cells is one of the biggest challenges in peptide drug development. This PNA-based system solves a specific problem: CPP charges interfering with cargo function. By acting as releasable molecular glue, PNAs could become a general platform for intracellular peptide delivery.
The Bigger Picture
Getting therapeutic peptides inside cells is one of the biggest challenges in drug development. This PNA bridge technology solves a specific and common problem — CPP interference — that has stalled many peptide drug candidates.
What This Study Doesn't Tell Us
Tested in one cell type with one cargo peptide (autophagy inducer). The generalizability to other functional peptides and cell types is unknown. The extent of intracellular PNA dissociation ("at least some portion") was not fully quantified. No in vivo testing. PNA synthesis adds cost and complexity to the system.
Questions This Raises
- ?Does this approach work with different cargo peptides beyond autophagy inducers?
- ?How quickly does the PNA bridge release its cargo once inside cells?
- ?Can this system be scaled for pharmaceutical manufacturing?
Trust & Context
- Key Stat:
- 8-mer PNA bridge enabled intracellular release of functional cargo without CPP charge interference
- Evidence Grade:
- Preliminary evidence. Proof-of-concept demonstrated with one cargo peptide in one cell type.
- Study Age:
- Published in 2020. PNA-based delivery continues to be explored as a platform technology.
- Original Title:
- Intracellular delivery of a peptide nucleic acid-based hybrid of an autophagy inducing peptide with a cell-penetrating peptide.
- Published In:
- Organic & biomolecular chemistry, 18(10), 1978-1986 (2020)
- Authors:
- Hakata, Yoshiyuki(3), Ishikawa, Suzuka, Ohtsuki, Takashi(7), Miyazawa, Masaaki, Kitamatsu, Mizuki
- Database ID:
- RPEP-04836
Evidence Hierarchy
Frequently Asked Questions
Why do cell-penetrating peptides interfere with their cargo?
CPPs are positively charged, which helps them cross cell membranes. But once inside, those charges can disrupt the cargo peptide's function by binding to cellular molecules or changing the cargo's shape.
How does the PNA bridge solve this?
The PNA acts like a temporary connector that holds the CPP and cargo together outside the cell. Once inside, the bridge releases the cargo, allowing it to work without the CPP's interfering charges.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-04836APA
Hakata, Yoshiyuki; Ishikawa, Suzuka; Ohtsuki, Takashi; Miyazawa, Masaaki; Kitamatsu, Mizuki. (2020). Intracellular delivery of a peptide nucleic acid-based hybrid of an autophagy inducing peptide with a cell-penetrating peptide.. Organic & biomolecular chemistry, 18(10), 1978-1986. https://doi.org/10.1039/c9ob02559f
MLA
Hakata, Yoshiyuki, et al. "Intracellular delivery of a peptide nucleic acid-based hybrid of an autophagy inducing peptide with a cell-penetrating peptide.." Organic & biomolecular chemistry, 2020. https://doi.org/10.1039/c9ob02559f
RethinkPeptides
RethinkPeptides Research Database. "Intracellular delivery of a peptide nucleic acid-based hybri..." RPEP-04836. Retrieved from https://rethinkpeptides.com/research/hakata-2020-intracellular-delivery-of-a
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.